Cargando…
Fast friends – Ubiquitin-like modifiers as engineered fusion partners
Ubiquitin and its relatives are major players in many biological pathways, and a variety of experimental tools based on biological chemistry or protein engineering is available for their manipulation. One popular approach is the use of linear fusions between the modifier and a protein of interest. S...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703124/ https://www.ncbi.nlm.nih.gov/pubmed/34840080 http://dx.doi.org/10.1016/j.semcdb.2021.11.013 |
_version_ | 1784839794816188416 |
---|---|
author | Asimaki, Evrydiki Petriukov, Kirill Renz, Christian Meister, Cindy Ulrich, Helle D. |
author_facet | Asimaki, Evrydiki Petriukov, Kirill Renz, Christian Meister, Cindy Ulrich, Helle D. |
author_sort | Asimaki, Evrydiki |
collection | PubMed |
description | Ubiquitin and its relatives are major players in many biological pathways, and a variety of experimental tools based on biological chemistry or protein engineering is available for their manipulation. One popular approach is the use of linear fusions between the modifier and a protein of interest. Such artificial constructs can facilitate the understanding of the role of ubiquitin in biological processes and can be exploited to control protein stability, interactions and degradation. Here we summarize the basic design considerations and discuss the advantages as well as limitations associated with their use. Finally, we will refer to several published case studies highlighting the principles of how they provide insight into pathways ranging from membrane protein trafficking to the control of epigenetic modifications. |
format | Online Article Text |
id | pubmed-9703124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Academic Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97031242022-12-01 Fast friends – Ubiquitin-like modifiers as engineered fusion partners Asimaki, Evrydiki Petriukov, Kirill Renz, Christian Meister, Cindy Ulrich, Helle D. Semin Cell Dev Biol Article Ubiquitin and its relatives are major players in many biological pathways, and a variety of experimental tools based on biological chemistry or protein engineering is available for their manipulation. One popular approach is the use of linear fusions between the modifier and a protein of interest. Such artificial constructs can facilitate the understanding of the role of ubiquitin in biological processes and can be exploited to control protein stability, interactions and degradation. Here we summarize the basic design considerations and discuss the advantages as well as limitations associated with their use. Finally, we will refer to several published case studies highlighting the principles of how they provide insight into pathways ranging from membrane protein trafficking to the control of epigenetic modifications. Academic Press 2022-12 /pmc/articles/PMC9703124/ /pubmed/34840080 http://dx.doi.org/10.1016/j.semcdb.2021.11.013 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Asimaki, Evrydiki Petriukov, Kirill Renz, Christian Meister, Cindy Ulrich, Helle D. Fast friends – Ubiquitin-like modifiers as engineered fusion partners |
title | Fast friends – Ubiquitin-like modifiers as engineered fusion partners |
title_full | Fast friends – Ubiquitin-like modifiers as engineered fusion partners |
title_fullStr | Fast friends – Ubiquitin-like modifiers as engineered fusion partners |
title_full_unstemmed | Fast friends – Ubiquitin-like modifiers as engineered fusion partners |
title_short | Fast friends – Ubiquitin-like modifiers as engineered fusion partners |
title_sort | fast friends – ubiquitin-like modifiers as engineered fusion partners |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703124/ https://www.ncbi.nlm.nih.gov/pubmed/34840080 http://dx.doi.org/10.1016/j.semcdb.2021.11.013 |
work_keys_str_mv | AT asimakievrydiki fastfriendsubiquitinlikemodifiersasengineeredfusionpartners AT petriukovkirill fastfriendsubiquitinlikemodifiersasengineeredfusionpartners AT renzchristian fastfriendsubiquitinlikemodifiersasengineeredfusionpartners AT meistercindy fastfriendsubiquitinlikemodifiersasengineeredfusionpartners AT ulrichhelled fastfriendsubiquitinlikemodifiersasengineeredfusionpartners |